HackensackUMC Advances Treatment of Thoracic Aortic Disease with Endovascular Procedures
December 18, 2015 09:25 AM
Hackensack University Medical Center has advanced treatment in emergent and elective endovascular thoracic vascular procedures by employing a new device that simplifies complex cases and reduces risks. Working in collaboration with Cook Medical, HackensackUMC participated in clinical trials that led to FDA approval of the lowest-profile, minimally-invasive endovascular thoracic stent graft.
In the first known case of its kind in the United States, Michael Wilderman, M.D., chief of Endovascular Surgery at HackensackUMC, placed the device in a ruptured and dissecting thoracic aneurysm.
Greg Simonian, M.D., executive vice chairman and chief of operations of the Heart and Vascular Hospital at HackensackUMC, used the first commercially-available device during an elective thoracic aneurysm repair just a few weeks ago.
“I am proud of our team for leading the way by safely and effectively providing groundbreaking technology in service of our patients,” said Martin S. Karpeh Jr., M.D., chairman of the Department of Surgery at HackensackUMC.
Dr. Wilderman continues to perform successful endovascular thoracic aneurysm repairs using this new technology.
“This represents yet another milestone in HackensackUMC’s commitment to outstanding patient care by providing early access to the latest technology and innovation in vascular surgery,” said
Dr. Wilderman. “These successful outcomes might not have occurred with the prior generation of standard thoracic endografts.”
“Our involvement in the clinical trials, which led to approval of the device, and our position among the lead enrollers was essential,” said Dr. Simonian. “Once the device received FDA approval, we received early access in order to optimize and expedite service to our patients.”
About Hackensack University Medical Center
HackensackUMC, a 775- bed nonprofit teaching and research hospital located in Bergen County, NJ, is the largest provider of inpatient and outpatient services in the state. Founded in 1888 as the county’s first hospital, it is the flagship hospital of Hackensack University Health Network, one of the largest health networks in the state comprised of 1,717 beds, more than 10,000 team members and 3,300 credentialed physicians. HackensackUMC was listed as the number one hospital in New Jersey in U.S. News & World Report’s 2015-16 Best Hospital rankings - maintaining its place atop the NJ rankings since the rating system was introduced. It was also named one of the top four New York Metro Area hospitals. HackensackUMC is the only hospital in New Jersey, New York and New England to be named one of Healthgrades America's 50 Best Hospitals™ nine consecutive years, and receive the Healthgrades Distinguished Hospital Award for Clinical Excellence™ 13 years in a row. The medical center is one of the top 25 green hospitals in the country according to Practice Greenhealth, and received 24 Gold Seals of Approval™ by The Joint Commission – more than any other hospital in the country. It was the first hospital in New Jersey and second in the nation to become a Magnet® recognized hospital for nursing excellence; receiving its fifth consecutive designation in 2014. HackensackUMC has created an entire campus of award-winning care, including: the John Theurer Cancer Center; the Heart & Vascular Hospital; and the Sarkis and Siran Gabrellian Women’s and Children’s Pavilion, which houses the Joseph M. Sanzari Children’s Hospital and Donna A. Sanzari Women’s Hospital, which was designed with The Deirdre Imus Environmental Health Center and listed on the Green Guide’s list of Top 10 Green Hospitals in the U.S. HackensackUMC is the Hometown Hospital of the New York Giants and the New York Red Bulls and is Official Medical Services Provider to The Barclays PGA Golf Tournament. It remains committed to its community through fundraising and community events. To learn more, visit: www.HackensackUMC.org.